Posted On: 10/07/2014 10:36:47 AM
Post# of 30066
MANF is real no doubt, but it is at least 15 months away from beginning a clinical trial and 4 years away from revenue.
It is possible a BP would partner with us after we get an Orphan IND, but I doubt the up front money they'd pay us would be enough for Gerald to accept the deal. I think it is more likely that we continue building multiple MANF orphans for the next 2 years and then after we've completed a Phase1/2 trial successfully, big BP deals will start falling in place and our MANF dream will come true!
But in the mean time we have Lympro. It isn't 4 years away from revenue, it is 4 months away. Lympro will be our near term savior.
There are a lot of posters on this mb that do not understand how the market responds to "pre-clinical drugs."
It is possible a BP would partner with us after we get an Orphan IND, but I doubt the up front money they'd pay us would be enough for Gerald to accept the deal. I think it is more likely that we continue building multiple MANF orphans for the next 2 years and then after we've completed a Phase1/2 trial successfully, big BP deals will start falling in place and our MANF dream will come true!
But in the mean time we have Lympro. It isn't 4 years away from revenue, it is 4 months away. Lympro will be our near term savior.
There are a lot of posters on this mb that do not understand how the market responds to "pre-clinical drugs."
(0)
(0)
